close
read more
Our group
Governance
Global presence
Key figures
History
Vocation, vision and values
Culture
Financial Results
Servier Institute
Our healthcare offering
Servier medicines
Generic medicines
e-Health solutions
Our areas of expertise
Research & Development
Therapeutic areas
Development portfolio
Clinical trials
Regulatory affairs
Pharmacovigilance
Servier Paris-Saclay R&D Institute
Medical promotion
Industry
Industrial quality
Production
Supply Chain
CDMO Services
Medical Affairs
Third-Party Sponsor studies
Business development & licensing
Our commitments
Patient
Ethics & Compliance
Commitment to transparency
CSR approach
Fight against counterfeiting
Supplier relationship
Servier endowment fund
Newsroom
News
Press release
Insight
Corporate publishing
Medical publishing
FR
MEDIATOR INFORMATION
NEWS
ROOM
News
Press release
Insight
Corporate publishing
Medical publishing
Olivier Laureau confirmed as Second Vice President of EFPIA
16 / 06 / 2021
News
PRISM BioLab, a new partner for Servier in immuno-oncology
16 / 06 / 2021
News
Parkinson: Servier and Oncodesign announce the selection of a preclinical candidate
14 / 06 / 2021
News
PatientView 2020 ranking: good results for Servier
10 / 06 / 2021
News
Vernalis and Servier achieve two milestones in their oncology drug discovery collaboration
10 / 06 / 2021
News
World Anti-Counterfeiting Day: Servier on the front line for patient safety
09 / 06 / 2021
News
World Environment Day: Servier more committed than ever!
04 / 06 / 2021
News
“Listening to go further together”: a film by Mécénat Servier!
03 / 06 / 2021
News
Sardona Therapeutics, winner of the Servier Spark Award
02 / 06 / 2021
News
Servier Spark Award goes to New Equilibrium Biosciences
02 / 06 / 2021
News
Servier has appointed Bertrand Renaud as Chief Patient Officer
31 / 05 / 2021
News
Béatrice Bihr joins Servier as Executive Vice President General Secretariat and member of the Group Executive Committee
26 / 05 / 2021
News